81 related articles for article (PubMed ID: 11844808)
21. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
Barrett-Lee P; Bidard FC; Pierga JY
Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
[TBL] [Abstract][Full Text] [Related]
22. Oral 5-FU analogues in the treatment of breast cancer.
Bunnell CA; Winer EP
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):39-43. PubMed ID: 9830624
[TBL] [Abstract][Full Text] [Related]
23. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
26. Novel oral chemotherapy agents.
Royce ME; Hoff PM; Pazdur R
Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
[TBL] [Abstract][Full Text] [Related]
27. Capecitabine in gastric cancer.
Okines A; Chau I; Cunningham D
Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
[TBL] [Abstract][Full Text] [Related]
28. [Fluorinated pyrimidines in oral treatment of advanced colorectal cancer].
Todnem K; Harboe K; Zotova L; Lind A; Ogreid D
Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2781-5. PubMed ID: 11107924
[TBL] [Abstract][Full Text] [Related]
29. The clinical pharmacology of the oral fluoropyrimidines.
Takimoto CH
Curr Probl Cancer; 2001; 25(3):134-213. PubMed ID: 11408845
[No Abstract] [Full Text] [Related]
30. Oral capecitabine (Xeloda) in cancer treatment.
Doyle DP; Engelking C
Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
[No Abstract] [Full Text] [Related]
31. Oral fluoropoyrimidines.
Hoff PM; Royce M; Medgyesy D; Brito R; Pazdur R
Semin Oncol; 1999 Dec; 26(6):640-6. PubMed ID: 10606257
[TBL] [Abstract][Full Text] [Related]
32. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
[TBL] [Abstract][Full Text] [Related]
33. Treatment of advanced disease and new drugs.
Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
[No Abstract] [Full Text] [Related]
34. [New therapeutic prospects with capecitabin in breast carcinoma].
Venturini M; Catzeddu T
Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671
[No Abstract] [Full Text] [Related]
35. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
36. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.
Szetela AB; Gibson DE
Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060
[TBL] [Abstract][Full Text] [Related]
37. Interaction between capecitabine and brivudin in a patient with breast cancer.
Baena-Cañada JM; Martínez MJ; García-Olmedo O; Jiménez-Bárcenas R; Muriel-Cueto P
Nat Rev Clin Oncol; 2010 Jan; 7(1):55-8. PubMed ID: 20029444
[TBL] [Abstract][Full Text] [Related]
38. Emerging role of capecitabine in gastric cancer.
Comella P; Franco L; Casaretti R; de Portu S; Menditto E
Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
[TBL] [Abstract][Full Text] [Related]
39. Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.
Milano G; Ferrero JM; François E
Br J Cancer; 2004 Aug; 91(4):613-7. PubMed ID: 15280932
[TBL] [Abstract][Full Text] [Related]
40. TAS-102: a novel antimetabolite for the 21st century.
Uboha N; Hochster HS
Future Oncol; 2016 Jan; 12(2):153-63. PubMed ID: 26616466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
